<p>Alpha Teknova（納斯達克代碼：TKNO - 獲取免費報告）於週四發佈了季度財報。該公司報告每股收益（EPS）為（$0.08），據 Zacks 報道。Alpha Teknova 的淨利潤率為負的 55.24%，股本回報率為負的 26.51%。Alpha Teknova 更新了其 2025 財年的指引，預計每股收益。</p>
<p>獲取 <strong>Alpha Teknova</strong> 警報：</p>
<h2>Alpha Teknova 股價下跌 2.8%</h2>
<p>週四中午交易時，納斯達克 TKNO 的股票下跌了$0.14，達到$4.81。該公司的交易量為 354,600 股，而其平均交易量為 337,389 股。該股票的市值為 2.5738 億美元，市盈率為-11.45，貝塔係數為 0.39。Alpha Teknova 的 52 周低點為$3.94，52 周高點為$10.37。該公司的 50 日移動平均線為$5.08，200 日移動平均線為$5.30。公司的流動比率為 5.87，速動比率為 4.70，債務與股本比率為 0.17。</p>
<h2>對 Alpha Teknova 的對沖基金看法</h2>
<p>對沖基金最近增加或減少了對該股票的持倉。Balyasny Asset Management L.P.在第二季度將其在 Alpha Teknova 的持股增加了 19.5%。Balyasny Asset Management L.P.現在擁有 1,000,484 股該公司的股票，價值$4,912,000，在此期間又購買了 163,526 股。Massar Capital Management LP 在第二季度將其在 Alpha Teknova 的持股增加了 185.7%。Massar Capital Management LP 現在擁有 200,000 股該公司的股票，價值$982,000，在此期間又購買了 130,000 股。Geode Capital Management LLC 在第二季度將其在 Alpha Teknova 的持倉增加了 64.4%。Geode Capital Management LLC 現在擁有 298,850 股該公司的股票，價值$1,468,000，在上個季度又收購了 117,016 股。Marshall Wace LLP 在第二季度將其在 Alpha Teknova 的持股增加了 83.0%。Marshall Wace LLP 現在擁有 90,032 股該公司的股票，價值$442,000，在此期間又收購了 40,825 股。最後，Goldman Sachs Group Inc.在第一季度將其在 Alpha Teknova 的持股增加了 68.3%。Goldman Sachs Group Inc.現在擁有 90,595 股該公司的股票，價值$470,000，在上個季度又收購了 36,763 股。目前，13.81% 的股票由機構投資者持有。</p>
<h2>華爾街分析師看法</h2>
<p>幾位股票分析師最近對 TKNO 股票發表了看法。Weiss Ratings 在 10 月 8 日的研究報告中重新發布了對 Alpha Teknova 股票的 “賣出（d-）” 評級。Stephens 在 7 月 22 日的研究報告中將 Alpha Teknova 的股票評級提高至 “強力買入”，並設定了$8.00 的目標價。一位投資分析師對該股票給予了強力買入評級，一位給予了買入評級，一位則對該公司的股票發出了賣出評級。根據 MarketBeat.com 的數據，Alpha Teknova 的平均評級為 “適度買入”，平均目標價為$10.00。</p>
<p><strong>閲讀我們對 TKNO 的最新分析</strong></p>
<h2>Alpha Teknova 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Alpha Teknova, Inc 在美國和國際上生產用於研究、發現、開發和商業化新療法、疫苗和分子診斷的關鍵試劑。該公司提供用於細胞生長和克隆的預製培養基板；用於細胞擴增的液體細胞培養基和補充劑；以及用於樣本操作、重懸和純化的分子生物學試劑。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票比 Alpha Teknova 更好</li>
<li>羅素 2000 指數，投資者如何利用它進行盈利交易</li>
<li>CAVA 股票在財報失利後尋找方向</li>
<li>什麼是特別股息？</li>
<li>3 只准備爆發的小型 AI 股票（均低於$20）</li>
<li>股票平均計算器</li>
<li>在下跌 16% 後，分析師關注 Meta Platforms 的大幅反彈</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VEtOTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VEtOTw"/></p>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Alpha Teknova 嗎？</h2>
<p>在考慮 Alpha Teknova 之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買……而 Alpha Teknova 並不在名單上。</p>
<p>雖然 Alpha Teknova 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

TKNO

<p>Alpha Teknova（納斯達克代碼：TKNO）報告季度每股收益為（$0.08），淨利潤率為負 55.24%，股本回報率為負 26.51%。該公司更新了 2025 財年的指引。股價下跌 2.8%，至$4.81，市值為 2.5738 億美元。分析師的評級不一，平均評級為 “適度買入”，目標價為$10.00。對沖基金增加了在該公司的持股，儘管最近的財報未達預期，但仍顯示出一些機構投資者的興趣</p>

<p>Alpha Teknova (NASDAQ:TKNO - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, Zacks reports. Alpha Teknova had a negative net margin of 55.24% and a negative return on equity of 26.51%. Alpha Teknova updated its FY 2025 guidance to EPS.</p>
<div class="lb-trans"><p>Alpha Teknova（納斯達克代碼：TKNO - 獲取免費報告）於週四發佈了季度財報。該公司報告每股收益（EPS）為（$0.08），據 Zacks 報道。Alpha Teknova 的淨利潤率為負的 55.24%，股本回報率為負的 26.51%。Alpha Teknova 更新了其 2025 財年的指引，預計每股收益。</p>
</div><p>Get <strong>Alpha Teknova</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Alpha Teknova</strong> 警報：</p>
</div><h2>Alpha Teknova Trading Down 2.8%</h2>
<div class="lb-trans"><h2>Alpha Teknova 股價下跌 2.8%</h2>
</div><p>Shares of NASDAQ TKNO traded down $0.14 during mid-day trading on Thursday, reaching $4.81. The company had a trading volume of 354,600 shares, compared to its average volume of 337,389. The stock has a market cap of $257.38 million, a price-to-earnings ratio of -11.45 and a beta of 0.39. Alpha Teknova has a 52 week low of $3.94 and a 52 week high of $10.37. The business's 50-day moving average is $5.08 and its 200-day moving average is $5.30. The company has a current ratio of 5.87, a quick ratio of 4.70 and a debt-to-equity ratio of 0.17.</p>
<div class="lb-trans"><p>週四中午交易時，納斯達克 TKNO 的股票下跌了$0.14，達到$4.81。該公司的交易量為 354,600 股，而其平均交易量為 337,389 股。該股票的市值為 2.5738 億美元，市盈率為-11.45，貝塔係數為 0.39。Alpha Teknova 的 52 周低點為$3.94，52 周高點為$10.37。該公司的 50 日移動平均線為$5.08，200 日移動平均線為$5.30。公司的流動比率為 5.87，速動比率為 4.70，債務與股本比率為 0.17。</p>
</div><h2>Hedge Funds Weigh In On Alpha Teknova</h2>
<div class="lb-trans"><h2>對 Alpha Teknova 的對沖基金看法</h2>
</div><p>Hedge funds have recently added to or reduced their stakes in the stock. Balyasny Asset Management L.P. increased its holdings in Alpha Teknova by 19.5% during the second quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company's stock valued at $4,912,000 after buying an additional 163,526 shares during the period. Massar Capital Management LP lifted its holdings in Alpha Teknova by 185.7% during the second quarter. Massar Capital Management LP now owns 200,000 shares of the company's stock worth $982,000 after buying an additional 130,000 shares during the period. Geode Capital Management LLC boosted its position in Alpha Teknova by 64.4% during the 2nd quarter. Geode Capital Management LLC now owns 298,850 shares of the company's stock valued at $1,468,000 after acquiring an additional 117,016 shares in the last quarter. Marshall Wace LLP increased its holdings in shares of Alpha Teknova by 83.0% in the 2nd quarter. Marshall Wace LLP now owns 90,032 shares of the company's stock valued at $442,000 after acquiring an additional 40,825 shares during the period. Finally, Goldman Sachs Group Inc. raised its position in shares of Alpha Teknova by 68.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 90,595 shares of the company's stock worth $470,000 after acquiring an additional 36,763 shares in the last quarter. 13.81% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>對沖基金最近增加或減少了對該股票的持倉。Balyasny Asset Management L.P.在第二季度將其在 Alpha Teknova 的持股增加了 19.5%。Balyasny Asset Management L.P.現在擁有 1,000,484 股該公司的股票，價值$4,912,000，在此期間又購買了 163,526 股。Massar Capital Management LP 在第二季度將其在 Alpha Teknova 的持股增加了 185.7%。Massar Capital Management LP 現在擁有 200,000 股該公司的股票，價值$982,000，在此期間又購買了 130,000 股。Geode Capital Management LLC 在第二季度將其在 Alpha Teknova 的持倉增加了 64.4%。Geode Capital Management LLC 現在擁有 298,850 股該公司的股票，價值$1,468,000，在上個季度又收購了 117,016 股。Marshall Wace LLP 在第二季度將其在 Alpha Teknova 的持股增加了 83.0%。Marshall Wace LLP 現在擁有 90,032 股該公司的股票，價值$442,000，在此期間又收購了 40,825 股。最後，Goldman Sachs Group Inc.在第一季度將其在 Alpha Teknova 的持股增加了 68.3%。Goldman Sachs Group Inc.現在擁有 90,595 股該公司的股票，價值$470,000，在上個季度又收購了 36,763 股。目前，13.81% 的股票由機構投資者持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師看法</h2>
</div><p>Several equities analysts have recently weighed in on TKNO shares. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Alpha Teknova in a research report on Wednesday, October 8th. Stephens raised shares of Alpha Teknova to a &#34;strong-buy&#34; rating and set a $8.00 price objective for the company in a research note on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Alpha Teknova has an average rating of &#34;Moderate Buy&#34; and an average price target of $10.00.</p>
<div class="lb-trans"><p>幾位股票分析師最近對 TKNO 股票發表了看法。Weiss Ratings 在 10 月 8 日的研究報告中重新發布了對 Alpha Teknova 股票的 “賣出（d-）” 評級。Stephens 在 7 月 22 日的研究報告中將 Alpha Teknova 的股票評級提高至 “強力買入”，並設定了$8.00 的目標價。一位投資分析師對該股票給予了強力買入評級，一位給予了買入評級，一位則對該公司的股票發出了賣出評級。根據 MarketBeat.com 的數據，Alpha Teknova 的平均評級為 “適度買入”，平均目標價為$10.00。</p>
</div><p><strong>Read Our Latest Analysis on TKNO</strong></p>
<div class="lb-trans"><p><strong>閲讀我們對 TKNO 的最新分析</strong></p>
</div><h2>Alpha Teknova Company Profile</h2>
<div class="lb-trans"><h2>Alpha Teknova 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.</p>
<div class="lb-trans"><p>Alpha Teknova, Inc 在美國和國際上生產用於研究、發現、開發和商業化新療法、疫苗和分子診斷的關鍵試劑。該公司提供用於細胞生長和克隆的預製培養基板；用於細胞擴增的液體細胞培養基和補充劑；以及用於樣本操作、重懸和純化的分子生物學試劑。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Alpha Teknova</li>
<li>Russell 2000 Index, How Investors Use it For Profitable Trading</li>
<li>CAVA Stock Looking for Direction After Earnings Miss</li>
<li>What is a Special Dividend?</li>
<li>3 Small AI Stocks Ready to Explode (All Under $20)</li>
<li>Stock Average Calculator</li>
<li>After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Alpha Teknova 更好</li>
<li>羅素 2000 指數，投資者如何利用它進行盈利交易</li>
<li>CAVA 股票在財報失利後尋找方向</li>
<li>什麼是特別股息？</li>
<li>3 只准備爆發的小型 AI 股票（均低於$20）</li>
<li>股票平均計算器</li>
<li>在下跌 16% 後，分析師關注 Meta Platforms 的大幅反彈</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VEtOTw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=TKNO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Alpha Teknova Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Alpha Teknova 嗎？</h2>
</div><p>Before you consider Alpha Teknova, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Alpha Teknova 之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買……而 Alpha Teknova 並不在名單上。</p>
</div><p>While Alpha Teknova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Alpha Teknova 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Alpha Teknova（NASDAQ:TKNO）公佈季度財報結果